Cancer is so often an agonizing diagnosis, one that can be that much more difficult for a patient to accept when the origin of the cancer cannot be traced. Novel genetic tests are just one of a few new options that may help us in situations where imaging, therapy, and other genetic markers have not been effective. Dr. F. Anthony Greco, director of the Sarah Cannon Cancer Center in Nashville, tells us that we appear to be making progress toward new ways to diagnose cancers of unknown primary origin. Dr. Larry Kaskel hosts.
Testing to Trace Cancers of Unknown Primary Origin
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Cancer is so often an agonizing diagnosis, one that can be that much more difficult for a patient to accept when the origin of the cancer cannot be traced. Novel genetic tests are just one of a few new options that may help us in situations where imaging, therapy, and other genetic markers have not been effective. Dr. F. Anthony Greco, director of the Sarah Cannon Cancer Center in Nashville, tells us that we appear to be making progress toward new ways to diagnose cancers of unknown primary origin. Dr. Larry Kaskel hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology
FCS and SHTG: Are We Meeting the Need?
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
Personalizing Care Within the RCC Treatment Paradigm
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Understanding hypertrophic cardiomyopathy and recent guidelines
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?